Compass Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Buy
1,242
+9
+0.7% +$1.94K 0.12% 45
2026
Q1
$268K Buy
1,233
+7
+0.6% +$1.55K 0.12% 47
2025
Q4
$280K Buy
1,226
+7
+0.6% +$1.59K 0.12% 40
2025
Q3
$282K Buy
1,219
+9
+0.7% +$1.83K 0.12% 41
2025
Q2
$225K Buy
1,210
+75
+7% +$13.9K 0.11% 45
2025
Q1
$238K Buy
1,135
+41
+4% +$7.97K 0.12% 39
2024
Q4
$194K Buy
+1,094
New +$201K 0.11% 39

Other funds holding ABBV

Compass Financial Services's ABBV Position: Q2 2026 in Review

Compass Financial Services increased its AbbVie (ABBV) stake by 0.73% in Q2 2026, buying an estimated $1.94K and bringing the position to 1,242 shares worth $313K. The position accounts for 0.12% of the portfolio, ranked #45.

Compass Financial Services first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Compass Financial Services held 1,242 shares of AbbVie worth $313K as of Q2 2026.
  • Compass Financial Services bought 9 AbbVie shares in Q2 2026, an estimated $1.94K.
  • AbbVie made up 0.12% of Compass Financial Services's portfolio in Q2 2026, its #45 holding.
  • Compass Financial Services first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Compass Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.